Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Tezepelumab on Asthma Control and Cough: A Prospective, Multi-center, Observational Study

NCT05922891 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05922891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05922891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Tezepelumab on Asthma Control and Cough: A Prospective, Multi-center, Observational Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 27, 2023
Completion date
September 20, 2025
Enrollment
92 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

asthma